Healthcare provider profile · identity verified

Philippe B Delalande, MD

Internal Medicine · KOKOMO, IN · NPI 1114961182

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	497	121
Rosuvastatin Calcium	Rosuvastatin Calcium	432	120
Levothyroxine Sodium	Levothyroxine Sodium	394	89
Amlodipine Besylate	Amlodipine Besylate	342	87
Lisinopril	Lisinopril	281	65
Losartan Potassium	Losartan Potassium	250	66
Metoprolol Succinate	Metoprolol Succinate	198	49
Metformin Hcl Er	Metformin Hcl	197	49
Tamsulosin Hcl	Tamsulosin Hcl	179	47
Metformin Hcl	Metformin Hcl	169	40
Pantoprazole Sodium	Pantoprazole Sodium	154	46
Omeprazole	Omeprazole	142	42
Trazodone Hcl	Trazodone Hcl	130	24
Trulicity	Dulaglutide	119	26
Pravastatin Sodium	Pravastatin Sodium	115	29
Gabapentin	Gabapentin	107	27
Hydrochlorothiazide	Hydrochlorothiazide	102	29
Simvastatin	Simvastatin	98	26
Jardiance	Empagliflozin	96	25
Olmesartan Medoxomil	Olmesartan Medoxomil	92	23
Furosemide	Furosemide	87	20
Potassium Chloride	Potassium Chloride	86	25
Albuterol Sulfate Hfa	Albuterol Sulfate	82	37
Meloxicam	Meloxicam	82	17
Glipizide Er	Glipizide	75	18
Sertraline Hcl	Sertraline Hcl	75	19
Allopurinol	Allopurinol	72	20
Carvedilol	Carvedilol	72	19
Duloxetine Hcl	Duloxetine Hcl	72	16
Montelukast Sodium	Montelukast Sodium	72	16
Escitalopram Oxalate	Escitalopram Oxalate	69	16
Metoprolol Tartrate	Metoprolol Tartrate	64	12
Eliquis	Apixaban	55	11
Januvia	Sitagliptin Phosphate	54	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	50	38
Ezetimibe	Ezetimibe	49	suppressed
Alendronate Sodium	Alendronate Sodium	48	13
Cephalexin	Cephalexin	47	35
Methylprednisolone	Methylprednisolone	47	40
Ozempic	Semaglutide	47	suppressed
Clopidogrel	Clopidogrel Bisulfate	46	13
Diclofenac Sodium	Diclofenac Sodium	46	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	12
Spironolactone	Spironolactone	44	11
Azithromycin	Azithromycin	42	40
Fluticasone Propionate	Fluticasone Propionate	41	19
Tramadol Hcl	Tramadol Hcl	41	20
Mounjaro	Tirzepatide	40	suppressed
Valsartan	Valsartan	39	12
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Glimepiride	Glimepiride	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Irbesartan	Irbesartan	32	suppressed
Pregabalin	Pregabalin	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	26
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	15
Xarelto	Rivaroxaban	29	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	22
Fluoxetine Hcl	Fluoxetine Hcl	26	11
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Famotidine	Famotidine	25	13
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Amoxicillin	Amoxicillin	23	20
Atenolol	Atenolol	23	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	23	23
Risedronate Sodium	Risedronate Sodium	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Finasteride	Finasteride	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Prednisone	Prednisone	21	16
Donepezil Hcl	Donepezil Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Baclofen	Baclofen	18	14
Buspirone Hcl	Buspirone Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Cyclosporine	Cyclosporine	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Glipizide	Glipizide	17	suppressed
Methimazole	Methimazole	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Naproxen	Naproxen	16	suppressed
Colestipol Hcl	Colestipol Hcl	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Prolia	Denosumab	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error